Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies-Reference-Cited by-同舟云学术

Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies

Published:2021-03-04 Issue:4 Volume:27 Page:717-726
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Chen Rita E.,Zhang Xianwen,Case James Brett^ORCID,Winkler Emma S.,Liu Yang,VanBlargan Laura A.,Liu Jianying,Errico John M.,Xie Xuping^ORCID,Suryadevara Naveenchandra^ORCID,Gilchuk Pavlo,Zost Seth J.^ORCID,Tahan Stephen,Droit Lindsay,Turner Jackson S.,Kim Wooseob^ORCID,Schmitz Aaron J.^ORCID,Thapa Mahima,Wang David,Boon Adrianus C. M.,Presti Rachel M.^ORCID,O’Halloran Jane A.,Kim Alfred H. J.^ORCID,Deepak Parakkal^ORCID,Pinto Dora,Fremont Daved H.^ORCID,Crowe James E.^ORCID,Corti Davide^ORCID,Virgin Herbert W.^ORCID,Ellebedy Ali H.^ORCID,Shi Pei-Yong^ORCID,Diamond Michael S.^ORCID

Funder

U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases

United States Department of Defense | Defense Advanced Research Projects Agency

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/s41591-021-01294-w.pdf

Reference57 articles.

1. Sempowski, G. D., Saunders, K. O., Acharya, P., Wiehe, K. J. & Haynes, B. F. Pandemic preparedness: Developing vaccines and therapeutic antibodies For COVID-19. Cell 181, 1458–1463 (2020).

2. Letko, M., Marzi, A. & Munster, V. Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses. Nat. Microbiol. 5, 562–569 (2020).